BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17400364)

  • 1. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results.
    Fotiadis NI; Sabharwal T; Morales JP; Hodgson DJ; O'Brien TS; Adam A
    Eur Urol; 2007 Sep; 52(3):777-84. PubMed ID: 17400364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
    Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
    Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.
    Yamakado K; Nakatsuka A; Kobayashi S; Akeboshi M; Takaki H; Kariya Z; Kinbara H; Arima K; Yanagawa M; Hori Y; Kato H; Sugimura Y; Takeda K
    Cardiovasc Intervent Radiol; 2006; 29(3):389-94. PubMed ID: 16502180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up.
    Arzola J; Baughman SM; Hernandez J; Bishoff JT
    Urology; 2006 Nov; 68(5):983-7. PubMed ID: 17095059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
    Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
    Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of renal tumors in the solitary kidney.
    Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
    Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous cryoablation of small kidney tumours under magnetic resonance imaging guidance: medium-term follow-up.
    Caviezel A; Terraz S; Schmidlin F; Becker C; Iselin CE
    Scand J Urol Nephrol; 2008; 42(5):412-6. PubMed ID: 18609277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
    Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
    Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P
    Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous radiofrequency ablation of renal tumours: case series of 11 tumours and review of published work.
    Watkins TW; Parkinson R
    Australas Radiol; 2007 Oct; 51(5):412-9. PubMed ID: 17803791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results].
    Boss A; Clasen S; Kuczyk M; Anastasiadis A; Schmidt D; Claussen CD; Schick F; Pereira PL
    Rofo; 2005 Aug; 177(8):1139-45. PubMed ID: 16021547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radiofrequency ablation for unresectable large hepatic tumours during hepatic blood flow occlusion in four patients.
    Miyamoto N; Tsuji K; Sakurai Y; Nishimori H; Kang JH; Mitsui S; Maguchi H
    Clin Radiol; 2004 Sep; 59(9):812-8. PubMed ID: 15351246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
    Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S
    Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Nakamura K; Inoue Y
    Cardiovasc Intervent Radiol; 2008; 31(1):122-30. PubMed ID: 17985181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
    Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
    J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.